Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical Hypertension is Scopus-indexed (Q1, CiteScore 7), WoS ESCI, DOAJ. Published by The Korean Society of Hypertension.
Checked against the index lists dated .
ISSN 2056-5909Verify ISSN ↗
Publisher: The Korean Society of Hypertension
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 73 / 409 | 82nd | Q1 |
| Internal Medicine | 35 / 179 | 80th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–present, best quartile Q1, CiteScore 7.
Clinical Hypertension is Q1 in Cardiology and Cardiovascular Medicine (rank 73 of 409) and Q1 in Internal Medicine (rank 35 of 179), by CiteScore 2025.
Clinical Hypertension is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7, which places it in quartile Q1 at the 82nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.439, quartile Q1, with an H-index of 30.
No article processing charge is recorded for it (source: OpenAlex). Confirm on the journal's own website, since some journals charge for extras such as colour figures.
Clinical Hypertension is published by The Korean Society of Hypertension. Its ISSN is 2056-5909.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Clinical Hypertension has an h-index of 39 and a 2-year mean of 4.82 citations per paper (OpenAlex). Its Scopus CiteScore is 7, quartile Q1. On 2-year citations it ranks #24 of 398 Scopus journals in Cardiology and Cardiovascular Medicine.
Clinical Hypertension published 46 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2024–2026), authors are most often from South Korea (39.6%), United States (11.6%) and China (9.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (5.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.